Williamson M, Press DJ, Hansen SA, Tomar A, et al. Population-level impact of adjuvant trastuzumab emtansine on the incidence of metastatic breast cancer: an epidemiological prediction model of women with HER2-positive early breast cancer and residual disease following neoadjuvant therapy. Breast Cancer 2023 Nov 1. doi: 10.1007/s12282-023-01514.
PMID: 37907759